Clinical Trials Logo

Clinical Trial Summary

During July 2019 to August 2020, a single-blind clinical trial was done to 36 patients with Graves' disease. At the beginning of the study, subjects were accommodated into 2 groups, 17 into PTU groups and 19 into methimazole groups. There were 24 subjects who finished the study, 13 from PTU group and 11 from methimazole group. Blood serum was collected for HOMA-IR, LDL-R, NFĸB, sICAM-1, sVCAM-1 and sE-selectin examination. Meanwhile stiffness and thickness of carotid artery was measured using PWV and cIMT.


Clinical Trial Description

This study was a single blind, randomized clinical trial study, conducted in Cipto Mangunkusumo National Referral Hospital from January 2019 to August 2020. We included all adult patient aged 18-65 years with newly diagnosed Graves' disease or no prior anti-thyroid drugs medication for more than 1 month, who agreed to participate in the study. The exclusion criteria was pregnancy, history of coronary heart disease, known malignancy, current use of immunosuppressive medication, sepsis, thyroid crisis, or having allergic reaction to anti-thyroid drugs and other severe side effect. Ethical approval was obtained from the Research Ethics Committee of the Faculty of Medicine, Universitas Indonesia with approval number KET-784/UN.2.F1/ETIK/PPM.00.02/2019. Study participant was observed every month for 3 months. Anti-thyroid drugs (PTU or methimazole) were given according to true simple randomization with adjusted dosage according to patient clinical assessment at every visit by their own endocrinologist. At baseline visit, first and third month follow up, blood serum was collected to analyse HOMA-IR, LDL-R, NFĸB, sICAM-1, sVCAM-1 and sE-selectin, meanwhile PWV and cIMT were measured using radiofrequency ultrasound examination of carotid arteries. Categorical data was presented in frequency (%), while numerical data was presented using mean (SD) if normally distributed or median (IQR) if not normally distributed. Correlation Pearson test was performed for normal distributed data and Spearman test for not normal distributed data. To analyze the changes in parameter from baseline, first and third month, repeated ANOVA and General Linear Model test was performed. For not normally distributed data, transformation into normally distributed data was performed and the data was presented as geometric mean (CI 95%). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05118542
Study type Interventional
Source Indonesia University
Contact
Status Completed
Phase Phase 3
Start date January 1, 2019
Completion date August 1, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04922801 - Optimising Molecular Radionuclide Therapy
Completed NCT02375451 - Effect of Childhood Radioiodine Therapy on Salivary Function N/A
Recruiting NCT00525122 - Treatment of M.Graves With Radioactive Iodine: Follow-up Study N/A
Completed NCT01306916 - Coexisting Thyroid Disease and Hyperparathyroidism N/A
Completed NCT03612908 - TSHβX1 and D2 THR92ALA in Pregnancy
Completed NCT03393728 - Heart Rate Variability and Hyperthyroidism: Evaluation of the Short-term Effects of Propanolol Phase 4
Completed NCT05049551 - Thyroid Uptake Quantification on a New Generation of Gamma Camera
Completed NCT02514187 - A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients N/A
Completed NCT01727973 - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy Phase 1/Phase 2
Completed NCT03951532 - Morbidity and Mortality Associated With the Care Journey in Children and Adolescents With Hyperthyroidism
Recruiting NCT02772705 - Comparison of SUV Using SPECT/CT Between Grave's Disease Patients and Normal Humans N/A
Active, not recruiting NCT02133040 - Effects of Hyperthyroidism on Amount and Activity of Brown Adipose Tissue
Active, not recruiting NCT01105923 - Study of an Intervention to Improve Problem List Accuracy and Use N/A
Recruiting NCT03303053 - Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism Phase 3
Completed NCT02499471 - Brown Adipose Tissue Activity and Thyroid Hormone N/A
Recruiting NCT04825964 - Exercise Capacity, Physical Activity Levels in Patients With Hyperthyroid
Not yet recruiting NCT03444246 - A Trial for the Evaluation of the Treatment and Outcome of Hyperthyroidism With Iodized Salt and Non Iodized Salt N/A
Recruiting NCT04932135 - Resting Heart Rate Monitoring for Optimized Treatment and Surveillance of Hyperthyroidism
Completed NCT02710799 - Evaluation of the Effects of Teleconsultations on a Endocrinology Referral List N/A
Active, not recruiting NCT01145040 - NOMOTHETICOS: Nonlinear Modelling of Thyroid Hormones' Effect on Thyrotropin Incretion in Confirmed Open-loop Situation